156 related articles for article (PubMed ID: 19262251)
41. Can preoperative MR imaging predict optic nerve invasion of retinoblastoma?
Song KD; Eo H; Kim JH; Yoo SY; Jeon TY
Eur J Radiol; 2012 Dec; 81(12):4041-5. PubMed ID: 23017191
[TBL] [Abstract][Full Text] [Related]
42. Cancer stem cell characteristics in retinoblastoma.
Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
[TBL] [Abstract][Full Text] [Related]
43. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of prognostic factors of retinoblastoma].
Lu Y; Wang JF
Zhonghua Yan Ke Za Zhi; 2009 Oct; 45(10):935-9. PubMed ID: 20137457
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
46. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
[TBL] [Abstract][Full Text] [Related]
47. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
48. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
[TBL] [Abstract][Full Text] [Related]
49. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
[TBL] [Abstract][Full Text] [Related]
50. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
51. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma.
Krishnakumar S; Mohan A; Kandalam M; Ramkumar HL; Venkatesan N; Das RR
Pediatr Blood Cancer; 2008 Feb; 50(2):402-6. PubMed ID: 17091485
[TBL] [Abstract][Full Text] [Related]
52. REG gene expression is associated with the infiltrating growth of gastric carcinoma.
Yonemura Y; Sakurai S; Yamamoto H; Endou Y; Kawamura T; Bandou E; Elnemr A; Sugiyama K; Sasaki T; Akiyama T; Takasawa S; Okamoto H
Cancer; 2003 Oct; 98(7):1394-400. PubMed ID: 14508825
[TBL] [Abstract][Full Text] [Related]
53. [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report].
Gavriş M; Neamţu S; Gavriş S; Ghiţuică A
Oftalmologia; 1999; 46(1):69-71. PubMed ID: 10641091
[TBL] [Abstract][Full Text] [Related]
54. Intracranial malignancy in patients with bilateral retinoblastoma.
Donoso LA; Shields JA; Felberg NT; Martyn LJ; Truex RC; D'Cruz CA
Retina; 1981; 1(1):67-74. PubMed ID: 15633409
[TBL] [Abstract][Full Text] [Related]
55. Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.
Chau KY; Manfioletti G; Cheung-Chau KW; Fusco A; Dhomen N; Sowden JC; Sasabe T; Mukai S; Ono SJ
Mol Med; 2003; 9(5-8):154-65. PubMed ID: 14571323
[TBL] [Abstract][Full Text] [Related]
56. Structure and function of the N-cadherin/catenin complex in retinoblastoma.
Van Aken EH; Papeleu P; De Potter P; Bruyneel E; Philippé J; Seregard S; Kvanta A; De Laey JJ; Mareel MM
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):595-602. PubMed ID: 11867572
[TBL] [Abstract][Full Text] [Related]
57. Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma.
Chantada GL; Gonzalez A; Fandino A; de Davila MT; Demirdjian G; Scopinaro M; Abramson D
J Pediatr Hematol Oncol; 2009 May; 31(5):325-9. PubMed ID: 19415010
[TBL] [Abstract][Full Text] [Related]
58. Canine ocular gliomas: a retrospective study.
Naranjo C; Schobert C; Dubielzig R
Vet Ophthalmol; 2008; 11(6):356-62. PubMed ID: 19046275
[TBL] [Abstract][Full Text] [Related]
59. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
60. [A clinicopathological study of 297 cases of retinoblastoma].
Yang H; Schilling H; Effert R; Wessing A
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):255-7, 15. PubMed ID: 11835815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
